Product Images Ramipril

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Ramipril NDC 51655-296 by Northwind Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 296 52

Label - 51655 296 52

This is a description of Ramipril capsules, USP with a strength of 5mg. It comes in a package size of 30 capsules, and it is a prescription-only medication. The capsules contain Ramipril USP 5mg and should be stored at room temperature. It is important to keep out of reach of children and store in the original container. There is additional information about the manufacturer and repackaging.*

Figure 1. Kaplan-Meier Estimates of the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes in the Ramipril Group and the Placebo Group - ramipril fig1

Figure 1. Kaplan-Meier Estimates of the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes in the Ramipril Group and the Placebo Group - ramipril fig1

The text appears to be a graph or table showing the proportion of patients over time with the use of Ramipril medication. The values range from 0.0 to 0.2, with a significance level of P=0.0001. The x-axis shows the days of follow-up up to 1500 days, while the y-axis shows the proportion of patients.*

Figure 2. The Beneficial Effect of Treatment with Ramipril on the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes Overall and in Various Subgroups - ramipril fig2

Figure 2. The Beneficial Effect of Treatment with Ramipril on the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes Overall and in Various Subgroups - ramipril fig2

This is a table related to different medical conditions and the number of patients that suffered from them. It also includes information about the incidence of composite outcomes in a placebo group and the relative risk in a Ramipril group. No further information is available.*

Chemical Structure - ramipril str

Chemical Structure - ramipril str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.